Cambium Biotech

Mushroom cultivation, products, and consultancy services in India.

About Cambium Biotech

Cambium Biotech is an Agriculture company. Mushroom cultivation, products, and consultancy services in India. It operates in the Agriculture and Industrial Goods & Manufacturing sectors. Its Indian entity Cambium Biotech Private Limited reported revenue of β‚Ή5.67 Cr. Cambium Biotech offers products and services including Button Mushrooms and Consultancy Services. Its focus areas include Food and Agriculture, Mushroom Farming, Mushroom Products and Industrial Supplies.

Company details

Cambium Biotech Private Limited is recognized as a pioneer in premium quality button mushrooms, having been founded in 2011. Fresh and processed mushrooms, along with spent compost, casing soil, spawn, and nutraceuticals, are produced by the company to promote sustainable farming and health benefits. Consultancy services are extended to B2B clients for farm design, management, and optimization, while mushroom tourism is facilitated at state-of-the-art facilities. Global distribution of products is achieved, focusing on quality and customer satisfaction without promotional emphasis.

  • Sectors
    Agriculture
    Industrial Goods & Manufacturing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website cambiumbiotech.com
  • Legal Name Cambium Biotech Private Limited
  • Date of Incorporation 27 Apr, 2011
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹5.67 Cr

    FY 2024 · +81% YoY

  • Indian entity net profit
    ₹53.6 Lakh

    FY 2024 · 9% margin

  • Indian entity EBITDA
    ₹1.87 Cr

    FY 2024 · 33% margin

Products & Services of Cambium Biotech

Cambium Biotech offers a comprehensive portfolio of products and services, including Button Mushrooms and Consultancy Services.

Button Mushrooms
Agricultural Products

Fresh and processed button mushrooms are cultivated and distributed for food uses, emphasizing quality and sustainability.

Consultancy Services
Business Services

Farm and project designing, planning, management, and optimization services are provided to enhance productivity and profitability for clients.

Board of directors of Cambium Biotech Private Limited (Cambium Biotech)

Cambium Biotech Private Limited is the primary company behind Cambium Biotech. The board of Cambium Biotech Private Limited currently have 3 directors; the longest-serving is Jha Amarnath Neelkamal, appointed in 2011. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Jha Amarnath Neelkamal
DIN 01660367
Director27 Apr 201115 yrs 6 moCambium Biotech Private Limited
Ambrish Kashyap
DIN 03538174
Director28 May 201115 yrs 5 moCambium Biotech Private Limited
Naresh Ramniwas Kedia
DIN 09157476
Director30 Jul 20224 yrs 3 moCambium Biotech Private Limited

Financials of Cambium Biotech

Figures of Cambium Biotech Private Limited, the primary company behind Cambium Biotech, for FY 2024. Revenue was ₹5.67 Cr (+81% year on year). Net profit was ₹53.6 Lakh (9% margin). EBITDA was ₹1.87 Cr (33% margin). Revenue has grown at a compounded annual rate of +68% over three years and +61% over five years.

  • ₹5.67 CrRevenue · FY 2024 · +81% YoY
  • ₹53.6 LakhNet profit · 9% margin
  • ₹1.87 CrEBITDA · 33% margin
  • ₹1.46 CrPaid-up capital
  • +68%Revenue CAGR, 3 years
  • +61%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Cambium Biotech Private Limited are on its company page.

Premium access

Detailed financial statements for Cambium Biotech

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cambium Biotech

The primary company behind Cambium Biotech, Cambium Biotech Private Limited, reported revenue of β‚Ή5.67 Cr for FY 2024, up 81% year on year.

Cambium Biotech Private Limited is recognized as a pioneer in premium quality button mushrooms, having been founded in 2011. Fresh and processed mushrooms, along with spent compost, casing soil, spawn, and nutraceuticals, are produced by the company to promote sustainable farming and health benefits. Consultancy services are extended to B2B clients for farm design, management, and optimization, while mushroom tourism is facilitated at state-of-the-art facilities. Global distribution of products is achieved, focusing on quality and customer satisfaction without promotional emphasis.

Cambium Biotech offers Button Mushrooms and Consultancy Services.

Cambium Biotech operates through Cambium Biotech Private Limited.

The legal entities of Cambium Biotech currently have 3 directors, including Jha Amarnath Neelkamal, Naresh Ramniwas Kedia, Ambrish Kashyap.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available